Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:2974-2985, 2006
DOI: 10.2337/db06-0690
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brissova, M.
Right arrow Articles by Powers, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brissova, M.
Right arrow Articles by Powers, A. C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pancreatic Islet Production of Vascular Endothelial Growth Factor-A Is Essential for Islet Vascularization, Revascularization, and Function

Marcela Brissova1, Alena Shostak1, Masakazu Shiota2, Peter O. Wiebe2, Greg Poffenberger1, Jeannelle Kantz2, Zhongyi Chen1, Chad Carr1, W. Gray Jerome3,4, Jin Chen4,5, H. Scott Baldwin6, Wendell Nicholson1, David M. Bader7, Thomas Jetton8, Maureen Gannon1,2, and Alvin C. Powers1,2,9

1 Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
2 Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
3 Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
4 Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee
5 Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
6 Division of Pediatric Cardiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
7 Stahlman Laboratory, Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
8 Division of Endocrinology and Metabolism, Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont
9 Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee

Address correspondence and reprint requests to Alvin C. Powers, Division of Diabetes, Endocrinology, and Metabolism, 715 PRB, Vanderbilt University, Nashville, TN 37232. E-mail: al.powers{at}vanderbilt.edu

Abbreviations: Ang, angiopoietin; VEGF, vascular endothelial growth factor

To investigate molecular mechanisms controlling islet vascularization and revascularization after transplantation, we examined pancreatic expression of three families of angiogenic factors and their receptors in differentiating endocrine cells and adult islets. Using intravital lectin labeling, we demonstrated that development of islet microvasculature and establishment of islet blood flow occur concomitantly with islet morphogenesis. Our genetic data indicate that vascular endothelial growth factor (VEGF)-A is a major regulator of islet vascularization and revascularization of transplanted islets. In spite of normal pancreatic insulin content and ß-cell mass, mice with ß-cell–reduced VEGF-A expression had impaired glucose-stimulated insulin secretion. By vascular or diffusion delivery of ß-cell secretagogues to islets, we showed that reduced insulin output is not a result of ß-cell dysfunction but rather caused by vascular alterations in islets. Taken together, our data indicate that the microvasculature plays an integral role in islet function. Factors modulating VEGF-A expression may influence islet vascularity and, consequently, the amount of insulin delivered into the systemic circulation.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
E. D. Berglund, C. Y. Li, G. Poffenberger, J. E. Ayala, P. T. Fueger, S. E. Willis, M. M. Jewell, A. C. Powers, and D. H. Wasserman
Glucose Metabolism In Vivo in Four Commonly Used Inbred Mouse Strains
Diabetes, July 1, 2008; 57(7): 1790 - 1799.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Olerud, M. Johansson, J. Lawler, N. Welsh, and P.-O. Carlsson
Improved Vascular Engraftment and Graft Function After Inhibition of the Angiostatic Factor Thrombospondin-1 in Mouse Pancreatic Islets
Diabetes, July 1, 2008; 57(7): 1870 - 1877.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. S. Tessem, J. N. Jensen, H. Pelli, X.-M. Dai, X.-H. Zong, E. R. Stanley, J. Jensen, and J. DeGregori
Critical Roles for Macrophages in Islet Angiogenesis and Maintenance During Pancreatic Degeneration
Diabetes, June 1, 2008; 57(6): 1605 - 1617.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Su, N. Zhang, J. He, S. Qu, S. Slusher, R. Bottino, S. Bertera, J. Bromberg, and H. H. Dong
Angiopoietin-1 Production in Islets Improves Islet Engraftment and Protects Islets From Cytokine-Induced Apoptosis
Diabetes, September 1, 2007; 56(9): 2274 - 2283.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. O. Goodarzi, D. M. Lehman, K. D. Taylor, X. Guo, J. Cui, M. J. Quinones, S. M. Clee, B. S. Yandell, J. Blangero, W. A. Hsueh, et al.
SORCS1: A Novel Human Type 2 Diabetes Susceptibility Gene Suggested by the Mouse
Diabetes, July 1, 2007; 56(7): 1922 - 1929.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.